| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.077 | 0.07 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.07 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |